Clinical Trial Update: Optimizing Timing of CABG in Patients Presenting With ACS and Treated With Ticagrelor [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update discusses optimizing the timing of coronary artery bypass grafting in patients with acute coronary syndrome treated with tica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome

Drugs mentioned

• BRILINTA (ticagrelor)

Snippet

Sponsor: Unity Health Toronto | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN